| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $1,557,258 ) |
| | 2024 | 2024 | GREENSTONE BIOSCIENCES, INC. | 3160 PORTER DR STE 200 | PALO ALTO | CA | 94304-1250 | SANTA CLARA | USA | R21TR004938 | AI/ML and iPSC-Derived Organoids for Myotonic Dystrophy Drug Discovery | 000 | 1 | NIH | 5/30/2024 | $110,000 |
| | 2024 | 2024 | GREENSTONE BIOSCIENCES, INC. | 3160 PORTER DR STE 200 | PALO ALTO | CA | 94304-1250 | SANTA CLARA | USA | R44HL170756 | Ethnically Diverse iPSC-Cardiomyocyte Panel for Pharmacogenomics and Drug Safety Testing | 000 | 2 | NIH | 8/5/2024 | $1,447,258 |
|
| Issue Date FY: 2023 ( Subtotal = $1,294,681 ) |
| | 2023 | 2023 | GREENSTONE BIOSCIENCES, INC. | 3160 PORTER DR STE 200 | PALO ALTO | CA | 94304-1250 | SANTA CLARA | USA | R44HL170756 | Ethnically Diverse iPSC-Cardiomyocyte Panel for Pharmacogenomics and Drug Safety Testing | 000 | 1 | NIH | 9/5/2023 | $1,294,681 |
|
|
